The aim of the study is to confirm the safe and successful use of the SmartGUIDE guidewire, when used in neuro interventions. The performance of the SmartGUIDE guidewire in terms of safe and successful navigation within the neurovasculature will be compared to standard of care guidewire on the market.
>18 years of age
Informed consent signed by the patient
Confirmed cerebral unruptured aneurysm treatable via transcatheter approach
Pregnancy or lactation
Known disorder of vascular fragility with propensity to vascular injury (e.g., Ehlers-Danlos syndrome)
Known prior vascular stenosis or dissection or injury to vessels intended to be catheterized during study procedures
Acute phase myocardial infarction or uncontrolled cardiac arrhythmia